SIRT1 and p53, effect on cancer, senescence and beyond

被引:282
作者
Yi, Jingjie [1 ,2 ,3 ]
Luo, Jianyuan [1 ,2 ,4 ]
机构
[1] Univ Massachusetts, Dept Canc Biol, Sch Med, Worcester, MA 01605 USA
[2] Univ Massachusetts, Ctr Canc, Sch Med, Worcester, MA 01605 USA
[3] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China
[4] Univ Maryland Baltimore Cty, Dept Pathol, Dept Med & Res Technol, Baltimore, MD 21201 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2010年 / 1804卷 / 08期
关键词
SIRT1; p53; Acetylation; Deacetylation; Cancer; Senescence; TUMOR-SUPPRESSOR GENE; DEPENDENT HISTONE DEACETYLASE; EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; REGULATES APOPTOSIS; SIR2-ALPHA PROTEIN; LIFE-SPAN; ACETYLATION; EXPRESSION; ACTIVATION;
D O I
10.1016/j.bbapap.2010.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NAD(+)-dependent Class III histone deacetylase SIRT1 is a multiple function protein critically involved in stress responses, cellular metabolism and aging through deacetylating a variety of substrates including p53, forkhead-box transcription factors, PGC-1 alpha, NF-kappa B, Ku70 and histones. The first discovered non-histone target of SIRT1, p53, is suggested to play a central role in SIRT1-mediated functions in tumorigenesis and senescence. SIRT1 was originally considered to be a potential tumor promoter since it negatively regulates the tumor suppressor p53 and other tumor suppressors. There is new evidence that SIRT1 acts as a tumor suppressor based on its role in negatively regulating beta-catenin and survivin. This review provides an overview of current knowledge of SIRT1-p53 signaling and controversies regarding the functions of SIRT1 in tumorigenesis. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:1684 / 1689
页数:6
相关论文
共 68 条
[1]   Sirtuin inhibitors [J].
Alcain, Francisco J. ;
Villalba, Jose M. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (03) :283-294
[2]   Sirtuin activators [J].
Alcain, Francisco J. ;
Villalba, Jose M. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (04) :403-414
[3]   Opinion - Survivin, cancer networks and pathway-directed drug discovery [J].
Altieri, Dario C. .
NATURE REVIEWS CANCER, 2008, 8 (01) :61-70
[4]   Analysis of DBC1 and its homologs suggests a potential mechanism for regulation of sirtuin domain deacetylases by NAD metabolites [J].
Anantharaman, Vivek ;
Aravind, L. .
CELL CYCLE, 2008, 7 (10) :1467-1472
[5]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[6]   Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration [J].
Araki, T ;
Sasaki, Y ;
Milbrandt, J .
SCIENCE, 2004, 305 (5686) :1010-1013
[7]   A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice [J].
Barger, Jamie L. ;
Kayo, Tsuyoshi ;
Vann, James M. ;
Arias, Edward B. ;
Wang, Jelai ;
Hacker, Timothy A. ;
Wang, Ying ;
Raederstorff, Daniel ;
Morrow, Jason D. ;
Leeuwenburgh, Christiaan ;
Allison, David B. ;
Saupe, Kurt W. ;
Cartee, Gregory D. ;
Weindruch, Richard ;
Prolla, Tomas A. .
PLOS ONE, 2008, 3 (06)
[8]   Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors [J].
Bradbury, C ;
Khanim, F ;
Hayden, R ;
Bunce, CM ;
White, DA ;
Drayson, MT ;
Craddock, C ;
Turner, BM .
LEUKEMIA, 2005, 19 (10) :1751-1759
[9]   How does SIRT1 affect metabolism, senescence and cancer? [J].
Brooks, Christopher L. ;
Gu, Wei .
NATURE REVIEWS CANCER, 2009, 9 (02) :123-128
[10]   Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation [J].
Brooks, CL ;
Gu, W .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :164-171